Saint Luke's Hospital-Quakertown Campus is a clinical research site located in Quakertown, Pennsylvania, United States 18951.
Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.
Saint Luke's Hospital-Quakertown Campus has participated in 14 clinical trials with 14 currently active.
Therapeutic areas: Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8.
Sponsors: National Cancer Institute (NCI), NRG Oncology, ECOG-ACRIN Cancer Research Group.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Quakertown
Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Saint Luke's Hospital-Quakertown Campus has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Saint Luke's Hospital-Quakertown Campus has 14 clinical trials on record, with 14 currently active. Their work covers Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8.
Saint Luke's Hospital-Quakertown Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.